Related Experiment Video
Updated: Oct 4, 2025

Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics
Published on: November 29, 2024
Hypermagnesaemia, but Not Hypomagnesaemia, Is a Predictor of Inpatient Mortality in Critically Ill Children with
Huabin Wang1,2, Junbin Huang1,2, Xinghan Jin3
1Division of Hematology/Oncology, Department of Pediatrics, The Seventh Affiliated Hospital of Sun Yat-Sen University, Shenzhen 518107, China.
Insights
Hypermagnesemia (high serum magnesium) is a risk factor for mortality in children with sepsis in the pediatric intensive care unit. Hypomagnesemia (low serum magnesium) did not significantly impact mortality outcomes.
Area of Science:
- Pediatric Critical Care Medicine
- Clinical Chemistry
- Sepsis Pathophysiology
Background:
- Sepsis is a life-threatening condition in children, with prognosis influenced by various factors.
- The role of serum magnesium levels in pediatric sepsis outcomes remains incompletely understood.
- Accurate assessment of prognostic indicators is crucial for timely intervention in pediatric intensive care units (PICU).
Purpose of the Study:
- To investigate the association between admission serum magnesium levels and inpatient mortality in pediatric sepsis patients.
- To determine if hypermagnesemia or hypomagnesemia predicts mortality risk in critically ill children with sepsis.
- To clarify the prognostic significance of serum magnesium in the PICU setting.
Main Methods:
- Retrospective analysis of clinical data from a Pediatric Intensive Care database.
- Inclusion of 974 critically ill children diagnosed with sepsis.
- Statistical analyses including chi-square tests, Kaplan-Meier survival analysis, and multivariate logistic regression.
Main Results:
- Hypermagnesemia was associated with significantly higher in-hospital mortality (14.5%) compared to the normal magnesium group (2.4%).
- Kaplan-Meier analysis indicated lower 30-day survival rates in the hypermagnesemia group.
- Multivariate regression identified hypermagnesemia as a significant risk factor for inpatient mortality (OR 4.22), while hypomagnesemia was not (OR 0.78).
Conclusions:
- Serum hypermagnesemia is a significant predictor of inpatient mortality in critically ill children with sepsis.
- Serum hypomagnesemia does not appear to be a significant predictor of mortality in this patient population.
- These findings highlight the importance of monitoring magnesium levels in pediatric sepsis management.
Objective:
The effect of serum magnesium on the prognosis of children with sepsis in the pediatric intensive care unit (PICU) is unclear. This study was designed to assess the risk of inpatient mortality for children with sepsis in the PICU based on serum magnesium levels at admission.
Methods:
We collected patients' clinical information from the Pediatric Intensive Care database and then performed locally weighted scatterplot smoothing (LOWESS) analysis, Kaplan-Meier analysis, and multivariate logistic regression to determine the relationship between admission serum magnesium and inpatient mortality in children with sepsis.
Results:
A total of 974 critically ill children with sepsis were included, with 246 patients in the hypomagnesemia group, 666 in the normal group, and 62 in the hypermagnesemia group. The chi-square test suggested that the hypermagnesemia group had higher in-hospital mortality than the normal group (14.5% vs. 2.4%, P < 0.001). Kaplan-Meier curves revealed that the 30-day overall survival rate was lower in the hypermagnesaemia group than in the normal group (P < 0.001). The multivariate logistic regression model revealed that hypermagnesaemia was a risk factor related to inpatient mortality (odds ratio 4.22, 95% CI 1.55-11.50), while hypomagnesaemia was not a significant factor for inpatient mortality (odds ratio 0.78, 95% CI 0.26-2.32).
Conclusion:
Hypermagnesaemia, but not hypomagnesaemia, is a predictor of inpatient mortality in critically ill children with sepsis.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury V: Interprofessional Care

